Gilead
Showing 1 - 25 of 1,090
HIV, Inpatient Facility Diagnoses Trial (Team Based Inpatient ARTAS, Standard of Care)
Not yet recruiting
- HIV Infections
- Inpatient Facility Diagnoses
- Team Based Inpatient ARTAS
- Standard of Care
- (no location specified)
May 18, 2023
Non Hodgkin Lymphoma Trial (TMhuCART19-IL18)
Not yet recruiting
- Non Hodgkin Lymphoma
- TMhuCART19-IL18
- (no location specified)
Aug 2, 2023
Esophagogastric Adenocarcinoma Trial (Sacituzumab govitecan)
Not yet recruiting
- Esophagogastric Adenocarcinoma
- Sacituzumab govitecan
- (no location specified)
Nov 9, 2023
Gastrointestinal Cancer Trial (Capecitabine, Sacituzumab govetican)
Not yet recruiting
- Gastrointestinal Cancer
- Capecitabine
- Sacituzumab govetican
- (no location specified)
Oct 2, 2023
Hiv Trial (DTG DT (6 x 5 mg), F/TAF TOS (3 x 60/7.5 mg))
Not yet recruiting
- Hiv
- DTG DT (6 x 5 mg)
- F/TAF TOS (3 x 60/7.5 mg)
- (no location specified)
Aug 8, 2022
HIV Prevention, PrEP Awareness, PrEP Uptake Trial (A chatbot designed to promote PrEP awareness and uptake for Black MSM,
Not yet recruiting
- HIV Prevention
- +2 more
- A chatbot designed to promote PrEP awareness and uptake for Black MSM
- General educational messages
- (no location specified)
Jul 27, 2023
Gland, Salivary Gland Cancers Trial in Houston (Sacituzumab Govitecan)
Not yet recruiting
- Gland
- Salivary Gland Cancers
- Sacituzumab Govitecan
-
Houston, TexasM D Anderson Cancer Center
May 22, 2023
Cervical Cancer Trial (Sacituzumab Govitecan)
Not yet recruiting
- Cervical Cancer
- Sacituzumab Govitecan
- (no location specified)
Apr 18, 2023
Triple Negative Breast Cancer Trial (Sacituzumab govitecan, Pembrolizumab)
Not yet recruiting
- Triple Negative Breast Cancer
- Sacituzumab govitecan
- Pembrolizumab
- (no location specified)
Oct 5, 2023
Hepatitis C Screening Alerts
Enrolling by invitation
- Hepatitis C
- Hepatitis C Screening Alerts in CHORUS™
- Standard of Care
-
Los Angeles, CaliforniaAIDS Healthcare Foundation
Jan 24, 2023
Hepatitis C Diagnosis to Treatment Management
Enrolling by invitation
- Hepatitis C
- Hepatitis C Treatment Alerts in CHORUS™
- Standard of Care
-
Los Angeles, CaliforniaAIDS Healthcare Foundation
Feb 2, 2023
HIV Trial in New Haven (EPIC-P)
Active, not recruiting
- HIV
- EPIC-P
-
New Haven, ConnecticutStorefront
Sep 2, 2022
Breast Cancer, Prostate Cancer Trial in Cleveland (NAVAH)
Not yet recruiting
- Breast Cancer
- Prostate Cancer
- NAVAH
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center, Case Comprehensiv
Jul 28, 2023
Cryptococcal Meningitis Trial in Kampala (Single dose liposomal Amphotericin and Fluconazole, Fluconazole)
Recruiting
- Cryptococcal Meningitis
- Single dose liposomal Amphotericin and Fluconazole
- Fluconazole
-
Kampala, Ugandainfectious Disease Institute Kampala,Uganda
Dec 21, 2022
Breast Cancer Trial (Early Point-of-Service Social and Behavioral Determinants of Health (SBDOH) Screening)
Not yet recruiting
- Breast Cancer
- Early Point-of-Service Social and Behavioral Determinants of Health (SBDOH) Screening
- (no location specified)
Sep 5, 2023
B-Cell Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia Trial in Tampa (Tecartus)
Recruiting
- B-Cell Lymphoblastic Leukemia
- Acute Lymphoblastic Leukemia
-
Tampa, FloridaMoffitt Cancer Center
Nov 28, 2023
HIV Trial in Thika (co-formulated 25mg TAF/ 200mg FTC)
Recruiting
- HIV Infections
- co-formulated 25mg TAF/ 200mg FTC
-
Thika, KenyaKenya Medical Research Institute - Partners in Health Research a
Jan 24, 2023
Ovarian Carcinoma Trial in New Haven (Sacituzumab govitecan)
Not yet recruiting
- Ovarian Carcinoma
- Sacituzumab govitecan
-
New Haven, ConnecticutSmilow Cancer Hospital at Yale New Haven
Aug 31, 2023
HIV Trial in Houston (B/FTC/TAF, Current ART)
Terminated
- HIV Infections
- B/FTC/TAF
- Current ART
-
Houston, TexasThomas Street Health Center
Sep 1, 2022
Head Neck, Squamous Cell Carcinoma of Head and Neck Trial in Houston (Pembrolizumab, Magrolimab, cetuximab)
Not yet recruiting
- Head Neck
- Squamous Cell Carcinoma of Head and Neck
- Pembrolizumab
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Sep 14, 2023
Hepatitis C Trial in Lexington (PREP-C, Modified ECHO, Patient Telemedicine Questionnaire)
Completed
- Hepatitis C
- PREP-C
- +2 more
-
Lexington, KentuckyUniversity of Kentucky
Jan 31, 2023
HIV/AIDS, Substance Use Disorders, Adherence, Medication Trial in Boylston (Digital pill, Truvada)
Localized Muscle Invasive Bladder Urothelial Carcinoma, Muscle-Invasive Bladder Carcinoma Trial in Cleveland (Sacituzumab
Not yet recruiting
- Localized Muscle Invasive Bladder Urothelial Carcinoma
- Muscle-Invasive Bladder Carcinoma
- Sacituzumab govitecan
- Adaptive Radiotherapy
-
Cleveland, OhioCleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Apr 18, 2023
Elimination of Hepatitis C Virus Among Users of Substances
Not yet recruiting
- Hepatitis C in Substance Users
- Sofosbuvir 400 MG / Velpatasvir 100 MG [Epclusa]
- (no location specified)
Aug 14, 2022